China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022

Aug, 2017   |   357  Pages   |   Renub Research   |   Format : PDF
As per Renub Research analysis China Cancer Test Market is projected to cross US$ 24 Billion by the end of 2022. In China, cancer cases are rising and are one of the major causes of deaths in urban and rural areas. In order to mitigate cancer prevalence in China; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and treatment. Early diagnosis programs include screening for breast and cervix cancer while prevention programs such as anti-smoking campaigns and immunization against hepatitis. Public awareness against cancer and the promotion of healthy lifestyle have also been carried out actively.

Growing Lung Cancer out of 26 Cancer Cases Studied in the Report

Cancer is one of the most significant public health burdens in China. China has exceptional number of lung cancer diagnoses and deaths than any other part of the world. The problem will keep mounting in near future as China’ air pollution goes mostly unchecked. In total 26 types of Cancer market and number of cases have been studied in the report.

Lung Cancer dominates the China Oncology (Cancer) Screening Tests Market and Volume

In Male: Lung Cancer is the most predominant cancer, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order).

In Female: Other than Lung, Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma.

High Cancer Mortality Rates

Cancer mortality rates in China have been rising rapidly over the past three decades. In urban region, the mortality of cancer is comparatively higher than in rural one. Out of 26 Types of Cancer studied in the report, Lung cancer accounts for the highest fatalities, followed by Digestive Tract Cancers (Stomach, Liver Cancer, Esophageal and Colorectum Cancer).

Renub Research report titled “China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022” studies the oncology market in China. This 357 page report with 314 Figures and 12 Tables provides in-depth analysis of China Cancer Tests Market and Volume. All 26 types of cancer in the report have been analyzed from 3 major viewpoints which further study it from 2 different perspectives.

1. China Cancer (Oncology) Screening Tests Market & Forecast

• Male
• Female

2. China Cancer (Oncology) Screening Tests Volume & Forecast

• Male
• Female

3. China Cancer (Oncology) Mortality Rate

All the 26 Cancer Market & Cases Studied in the Report are as Follows:

1. Lip, oral cavity, & pharynx (except nasopharynx)
2. Nasopharynx
3. Esophagus
4. Stomach
5. Colorectum
6. Liver
7. Gallbladder
8. Pancreas
9. Larynx
10. Lung
11. Other thoracic organs
12. Bone
13. Melanoma of the skin
14. Breast
15. Cervix
16. Uterus
17. Ovary
18. Prostate
19. Testis
20. Kidney
21. Bladder
22. Brain, CNS
23. Thyroid
24. Lymphoma
25. Leukemia
26. All other sites and unspecified
1. Research Findings

2. China – Cancer Test Market (2010 – 2022)
2.1 Male – Cancer Test Market & Forecast

2.2 Female – Cancer Test Market & Forecast

3. China – Cancer Test Volume (2010 – 2022)
3.1 Male – Cancer Test Volume & Forecast

3.2 Female – Cancer Test Volume & Forecast

4. China – Cancer Test Market Share (2010 – 2022)
4.1 Male – Cancer Test Market Share & Forecast

4.2 Female – Cancer Test Market Share & Forecast

5. China Oncology Test Market Share - Male Vs Female

6. China – Cancer Test Volume Share (2010 – 2022)
6.1 Male – Cancer Test Volume Share & Forecast

6.2 Female – Cancer Test Volume Share & Forecast

7. China Oncology Test Volume Share - Male Vs Female

8. China – Cancer Test Market (2010 – 2022)
8.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market & Forecast
8.1.1 Male – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market
8.1.2 Female – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market

8.2 Nasopharynx Cancer Test Market & Forecast
8.2.1 Male – Nasopharynx Cancer Test Market
8.2.2 Female – Nasopharynx Cancer Test Market

8.3 Esophagus Cancer Test Market & Forecast
8.3.1 Male – Esophagus Cancer Test Market
8.3.2 Female – Esophagus Cancer Test Market

8.4 Stomach Cancer Test Market & Forecast
8.4.1 Male – Stomach Cancer Test Market
8.4.2 Female – Stomach Cancer Test Market

8.5 Colorectum Cancer Test Market
8.5.1 Male – Colorectum Cancer Test Market
8.5.2 Female – Colorectum Cancer Test Market

8.6 Liver Cancer Test Market & Forecast
8.6.1 Male – Liver Cancer Test Market
8.6.2 Female – Liver Cancer Test Market

8.7 Gallbladder Cancer Test Market & Forecast
8.7.1 Male – Gallbladder Cancer Test Market
8.7.2 Female – Gallbladder Cancer Test Market

8.8 Pancreas Cancer Test Market & Forecast
8.8.1 Male – Pancreas Cancer Test Market
8.8.2 Female – Pancreas Cancer Test Market

8.9 Larynx Cancer Test Market & Forecast
8.9.1 Male – Larynx Cancer Test Market
8.9.2 Female – Larynx Cancer Test Market

8.10 Lung Cancer Test Market & Forecast
8.10.1 Male – Lung Cancer Test Market
8.10.2 Female – Lung Cancer Test Market

8.11 Other Thoracic Organs Cancer Test Market & Forecast
8.11.1 Male – Other Thoracic Organs Cancer Test Market
8.11.2 Female – Other Thoracic Organs Cancer Test Market

8.12 Bone Cancer Test Market & Forecast
8.12.1 Male – Bone Cancer Test Market
8.12.2 Female – Bone Cancer Test Market

8.13 Melanoma Skin Cancer Test Market & Forecast
8.13.1 Male – Melanoma Skin Cancer Test Market
8.13.2 Female – Melanoma Skin Cancer Test Market

8.14 Breast Cancer Test Market & Forecast
8.14.1 Male – Breast Cancer Test Market
8.14.2 Female – Breast Cancer Test Market

8.15 Cervix Cancer Test Market & Forecast

8.16 Uterus Cancer Test Market & Forecast

8.17 Ovary Cancer Test Market & Forecast

8.18 Prostate Cancer Test Market & Forecast

8.19 Testis Cancer Test Market

8.20 Kidney Cancer Test Market & Forecast
8.20.1 Male – Kidney Cancer Test Market
8.20.2 Female – Kidney Cancer Test Market

8.21 Bladder Cancer Test Market & Forecast
8.21.1 Male – Bladder Cancer Test Market
8.21.2 Female – Bladder Test Market

8.22 Brain, CNS Cancer Test Market & Forecast
8.22.1 Male – Brain, CNS Cancer Test Market
8.22.2 Female – Brain, CNS Cancer Test Market

8.23 Thyroid Cancer Test Market & Forecast
8.23.1 Male – Thyroid Cancer Test Market
8.23.2 Female – Thyroid Cancer Test Market

8.24 Lymphoma Cancer Test Market
8.24.1 Male – Lymphoma Cancer Test Market
8.24.2 Female – Lymphoma Cancer Test Market

8.25 Leukemia Cancer Test Market
8.25.1 Male – Leukemia Cancer Test Market
8.25.2 Female – Leukemia Cancer Test Market

8.26 All Other and Unspecified Test Market
8.26.1 Male – All Other and Unspecified Cancer Test Market
8.26.2 Female – All Other and Unspecified Cancer Test Market

9. China – Oncology Test Volume (2010 – 2022)
9.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume
9.1.1 Male – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume
9.1.2 Female – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume

9.2 Nasopharynx Cancer Test Volume
9.2.1 Male – Nasopharynx Cancer Test Volume
9.2.2 Female – Nasopharynx Cancer Test Volume

9.3 Esophagus Cancer Test Volume
9.3.1 Male – Esophagus Cancer Test Volume
9.3.2 Female – Esophagus Cancer Test Volume

9.4 Stomach Cancer Test Volume
9.4.1 Male – Stomach Cancer Test Volume
9.4.2 Female – Stomach Cancer Test Volume

9.5 Colorectum Cancer Test Volume
9.5.1 Male – Colorectum Cancer Test Volume
9.5.2 Female – Colorectum Cancer Test Volume

9.6 Liver Cancer Test Volume
9.6.1 Male – Liver Cancer Test Volume
9.6.2 Female – Liver Cancer Test Volume

9.7 Gallbladder Cancer Test Volume
9.7.1 Male – Gallbladder Cancer Test Volume
9.7.2 Female – Gallbladder Cancer Test Volume

9.8 Pancreas Cancer Test Volume
9.8.1 Male – Pancreas Cancer Test Volume
9.8.2 Female – Pancreas Cancer Test Volume

9.9 Larynx Cancer Test Volume
9.9.1 Male – Larynx Cancer Test Volume
9.9.2 Female – Larynx Cancer Test Volume

9.10 Lung Cancer Test Volume
9.10.1 Male – Lung Cancer Test Volume
9.10.2 Female – Lung Cancer Test Volume

9.11 Other Thoracic Organs Test Volume
9.11.1 Male – Other Thoracic Organs Cancer Test Volume
9.11.2 Female – Other Thoracic Organs Cancer Test Volume

9.12 Bone Cancer Test Volume
9.12.1 Male – Bone Cancer Test Volume
9.12.2 Female – Bone Cancer Test Volume

9.13 Melanoma of the Skin Cancer Test Volume
9.13.1 Male – Melanoma of the Skin Cancer Test Volume
9.13.2 Female – Melanoma of the Skin Cancer Test Volume

9.14 Breast Cancer Test Volume
9.14.1 Male – Breast Cancer Test Volume
9.14.2 Female – Breast Cancer Test Volume

9.15 Cervix Cancer Test Volume

9.16 Uterus Cancer Test Volume

9.17 Ovary Cancer Test Volume

9.18 Prostate Cancer Test Volume

9.19 Testis Cancer Test Volume

9.20 Kidney Cancer Test Volume
9.20.1 Male – Kidney Cancer Test Volume
9.20.2 Female – Kidney Cancer Test Volume

9.21 Bladder Cancer Test Volume
9.21.1 Male – Bladder Cancer Test Volume
9.21.2 Female – Bladder Cancer Test Volume

9.22 Brain, CNS Cancer Test Volume
9.22.1 Male – Brain, CNS Cancer Test Volume
9.22.2 Female – Brain, CNS Cancer Test Volume

9.23 Thyroid Cancer Test Volume
9.23.1 Male – Thyroid Cancer Test Volume
9.23.2 Female – Thyroid Cancer Test Volume

9.24 Lymphoma Cancer Test Volume
9.24.1 Male – Lymphoma Cancer Test Volume
9.24.2 Female – Lymphoma Cancer Test Volume

9.25 Leukemia Cancer Test Volume
9.25.1 Male – Leukemia Cancer Test Volume
9.25.2 Female – Leukemia Cancer Test Volume

9.26 All Other and Unspecified Test Volume
9.26.1 Male – All Other and Unspecified Cancer Test Volume
9.26.2 Female – All Other and Unspecified Cancer Test Volume

10. China – Cancer Deaths (2010 – 2022)

11. China – Cancer Mortality Rate (2015)
11.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx)

11.2 Nasopharynx

11.3 Esophagus

11.4 Stomach

11.5 Colorectum

11.6 Liver

11.7 Gallbladder

11.8 Pancreas

11.9 Larynx

11.10 Lung

11.11 Other Thoracic Organs

11.12 Bone

11.13 Melanoma of the skin

11.14 Breast

11.15 Cervix

11.16 Uterus

11.17 Ovary

11.18 Prostate

11.19 Testis

11.20 Kidney

11.21 Bladder

11.22 Brain, CNS

11.23 Thyroid

11.24 Lymphoma

11.25 Leukemia

11.26 All Other and Unspecified

12. China Healthcare Policies and Reimbursement
12.1 The Healthcare Policies

12.2 China Healthcare Insurance Schemes
12.2.1 NRCMS
12.2.2 UEBMI
12.2.3 URBMI
12.2.4 Private Health Insurance

13. Appendix

List of Figures

Figure 2‑1: China – Cancer Test Market (Billion US$), 2010 - 2016
Figure 2‑2: China – Forecast for Oncology Test Market (Billion US$), 2017 - 2022
Figure 2‑3: China – Cancer (Male) Test Market (Billion US$), 2010 - 2016
Figure 2‑4: China – Forecast for Cancer (Male) Test Market (Billion US$), 2017 - 2022
Figure 2‑5: China – Cancer (Female) Test Market (Billion US$), 2010 - 2016
Figure 2‑6: China – Forecast for Cancer (Female) Test Market (Billion US$), 2017 - 2022

Figure 3‑1: China – Cancer Test Volume (Million), 2010 - 2016
Figure 3‑2: China – Forecast for Cancer Test Volume (Million), 2017 - 2022
Figure 3‑3: China – Oncology (Male) Test Volume (Million), 2010 - 2016
Figure 3‑4: China – Forecast for Oncology (Male) Test Volume (Million), 2017 - 2022
Figure 3‑5: China – Oncology (Female) Test Volume (Million), 2010 - 2016
Figure 3‑6: China – Forecast for Oncology (Female) Test Volume (Million), 2017 - 2022

Figure 5‑1: China Cancer Test Market Share (%) - Male Vs Female, 2016 - 2022

Figure 7‑1: China Cancer Test Volume Share (%) - Male Vs Female, 2016 - 2022

Figure 8‑1: China – Lip, oral cavity, & pharynx (except nasopharynx) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑2: China – Forecast for Lip, oral cavity, & pharynx (except nasopharynx) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑3: China – Lip, oral cavity, & pharynx (except nasopharynx) (Male) Test Market (Million US$), 2010 - 2016
Figure 8‑4: China – Forecast for Lip, oral cavity, & pharynx (except nasopharynx) (Male) Test Market (Million US$), 2017 - 2022
Figure 8‑5: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑6: China – Forecast for Lip, oral cavity, & pharynx (except nasopharynx) (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑7: China – Nasopharynx Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑8: China – Forecast for Nasopharynx Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑9: China – Nasopharynx (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑10: China – Forecast for Nasopharynx (Male) Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑11: China – Nasopharynx (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑12: China – Forecast for Nasopharynx (Female) Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑13: China – Esophagus Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑14: China – Forecast for Esophagus Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑15: China – Esophagus (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑16: China – Forecast for Esophagus (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑17: China – Esophagus (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑18: China – Forecast For Esophagus (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑19: China – Stomach Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑20: China – Forecast for Stomach Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑21: China – Stomach (Male) Test Market (Million US$), 2010 - 2016
Figure 8‑22: China – Forecast for Stomach (Male) Test Market (Million US$), 2017 - 2022
Figure 8‑23: China – Stomach (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑24: China – Forecast for Stomach (Female) Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑25: China – Colorectum Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑26: China – Forecast for Colorectum Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑27: China – Colorectum (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑28: China – Forecast for Colorectum (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑29: China – Colorectum (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑30: China – Forecast for Colorectum (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑31: China – Liver Cancer Test Market (Million US$), 2010 – 2016
Figure 8‑32: China – Forecast for Liver Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑33: China – Liver (Male) Test Market (Million US$), 2010 - 2016
Figure 8‑34: China – Forecast for Liver (Male) Test Market (Million US$), 2017 - 2022
Figure 8‑35: China – Liver (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑36: China – Forecast for Liver (Female) Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑37: China – Gallbladder Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑38: China – Forecast for Gallbladder Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑39: China – Gallbladder (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑40: China – Forecast for Gallbladder (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑41: China – Gallbladder (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑42: China – Forecast for Gallbladder (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑43: China – Pancreas Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑44: China – Forecast for Pancreas Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑45: China – Pancreas (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑46: China – Forecast for Pancreas (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑47: China – Pancreas (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑48: China – Forecast for Pancreas (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑49: China – Larynx Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑50: China – Forecast for Larynx Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑51: China – Larynx (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑52: China – Forecast for Larynx (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑53: China – Larynx (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑54: China – Forecast for Larynx (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑55: China – Lung Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑56: China – Forecast for Lung Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑57: China – Lung (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑58: China – Forecast for Lung (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑59: China – Lung (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑60: China – Forecast for Lung (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑61: China – Other Thoracic Organs Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑62: China – Forecast for Other Thoracic Organs Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑63: China – Other Thoracic Organs (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑64: China – Forecast for Other Thoracic Organs (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑65: China – Other thoracic organs (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑66: China – Forecast for Other thoracic organs (Female) Test Market (Million US$), 2017 - 2022
Figure 8‑67: China – Bone Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑68: China – Forecast for Bone Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑69: China – Bone (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑70: China – Forecast for Bone (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑71: China – Bone (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑72: China – Forecast for Bone (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑73: China – Melanoma of the Skin Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑74: China – Forecast for Melanoma of the Skin Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑75: China – Melanoma Skin Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑76: China – Forecast for Melanoma Skin Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑77: China – Melanoma Skin (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑78: China – Forecast for Melanoma of Skin (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑79: China – Breast Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑80: China – Forecast for Breast Test Market (Million US$), 2017 - 2022
Figure 8‑81: China – Breast (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑82: China – Forecast for Breast (Male) Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑83: China – Breast (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑84: China – Forecast for Breast (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑85: China – Cervix Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑86: China – Forecast for Cervix Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑87: China – Uterus Test Market (Million US$), 2010 - 2016
Figure 8‑88: China – Forecast for Uterus Test Market (Million US$), 2017 - 2022
Figure 8‑89: China – Ovary Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑90: China – Forecast for Ovary Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑91: China – Prostate Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑92: China – Forecast for Prostate Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑93: China – Testis Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑94: China – Forecast for Testis Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑95: China – Kidney Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑96: China – Forecast for Kidney Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑97: China – Kidney (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑98: China – Forecast for Kidney (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑99: China – Kidney (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑100: China – Forecast for Kidney (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑101: China – Bladder Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑102: China – Forecast for Bladder Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑103: China – Bladder (Male) Test Market (Million US$), 2010 - 2016
Figure 8‑104: China – Forecast for Bladder (Male) Test Market (Million US$), 2017 - 2022
Figure 8‑105: China – Bladder (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑106: China – Forecast for Bladder (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑107: China – Brain, CNS Test Market (Million US$), 2010 - 2016
Figure 8‑108: China – Forecast for Brain, CNS Test Market (Million US$), 2017 - 2022
Figure 8‑109: China – Brain, CNS (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑110: China – Forecast for Brain, CNS (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑111: China – Brain, CNS (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑112: China – Forecast for Brain, CNS (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑113: China – Thyroid Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑114: China – Forecast for Thyroid Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑115: China – Thyroid (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑116: China – Forecast for Thyroid (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑117: China – Thyroid (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑118: China – Forecast for Thyroid (Female) Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑119: China – Lymphoma Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑120: China – Forecast for Lymphoma Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑121: China – Lymphoma (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑122: China – Forecast for Lymphoma (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑123: China – Lymphoma (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑124: China – Forecast for Lymphoma (Female) Cancer Test Market (Million US$), 2017 – 2022
Figure 8‑125: China – Leukemia Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑126: China – Forecast for Leukemia Test Market (Million US$), 2017 - 2022
Figure 8‑127: China – Leukemia (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑128: China – Forecast for Leukemia (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑129: China – Leukemia (Female) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑130: China – Forecast for Leukemia (Female) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑131: China – All Other and Unspecified Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑132: China – Forecast for All Other and Unspecified Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑133: China – All Other and Unspecified (Male) Cancer Test Market (Million US$), 2010 - 2016
Figure 8‑134: China – Forecast for All Other and Unspecified (Male) Cancer Test Market (Million US$), 2017 - 2022
Figure 8‑135: China – All Other and Unspecified (Female) Cancer Test Market (Million US$), 2010 – 2016
Figure 8‑136: China – Forecast for All Other and Unspecified (Female) Cancer Test Market (Million US$), 2017 – 2022

Figure 9‑1: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑2: China – Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑3: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑4: China – Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑5: China – Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑6: China – Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑7: China – Nasopharynx Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑8: China – Forecast for Nasopharynx Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑9: China – Nasopharynx (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑10: China – Forecast for Nasopharynx (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑11: China – Nasopharynx (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑12: China – Forecast for Nasopharynx (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑13: China – Esophagus Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑14: China – Forecast for Esophagus Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑15: China – Esophagus (Male) Cancer Test Volume (Thousand), 2010 -2016
Figure 9‑16: China – Forecast for Esophagus (Male) Cancer Test Volume (Thousand), 2017 -2022
Figure 9‑17: China – Esophagus (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑18: China – Forecast for Esophagus (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑19: China – Stomach Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑20: China – Forecast for Stomach Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑21: China – Stomach (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑22: China – Forecast for Stomach (Male) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑23: China – Stomach (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑24: China – Stomach (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑25: China – Colorectum Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑26: China – Forecast for Colorectum Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑27: China – Colorectum (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑28: China – Forecast for Colorectum (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑29: China – Colorectum (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑30: China – Forecast for Colorectum (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑31: China – Liver Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑32: China – Forecast for Liver Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑33: China – Liver (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑34: China – Forecast for Liver (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑35: China – Liver (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑36: China – Forecast for Liver (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑37: China – Gallbladder Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑38: China – Forecast for Gallbladder Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑39: China – Gallbladder (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑40: China – Forecast for Gallbladder (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑41: China – Gallbladder (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑42: China – Forecast for Gallbladder (Female) Test Volume (Thousand), 2017 – 2022
Figure 9‑43: China – Pancreas Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑44: China – Forecast for Pancreas Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑45: China – Pancreas (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑46: China – Forecast for Pancreas (Male) Test Volume (Thousand), 2017 - 2022
Figure 9‑47: China – Pancreas (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑48: China – Forecast for Pancreas (Female) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑49: China – Larynx Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑50: China – Forecast for Larynx Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑51: China – Larynx (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑52: China – Forecast for Larynx (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑53: China – Larynx (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑54: China – Forecast for Larynx (Female) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑55: China – Lung Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑56: China – Forecast for Lung Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑57: China – Lung (Male) Cacner Test Volume (Thousand), 2010 - 2016
Figure 9‑58: China – Forecast for Lung (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑59: China – Lung (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑60: China – Forecast for Lung (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑61: China – Other Thoracic Organs Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑62: China – Forecast for Other Thoracic Organs Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑63: China – Other Thoracic Organs (Male) Cancer Test Volume (Thousand), 2010 – 2016
Figure 9‑64: China – Forecast for Other Thoracic Organs (Male) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑65: China – Other Thoracic Organs (Female) Cancer Test Volume (Thousand), 2010 – 2016
Figure 9‑66: China – Forecast for Other thoracic organs (Female) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑67: China – Bone Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑68: China – Forecast for Bone Test Volume (Thousand), 2017 - 2022
Figure 9‑69: China – Bone (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑70: China – Forecast for Bone (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑71: China – Bone (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑72: China – Forecast for Bone (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑73: China – Melanoma of the Skin Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑74: China – Forecast for Melanoma of the Skin Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑75: China – Melanoma of the Skin (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑76: China – Forecast for Melanoma of the skin (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑77: China – Melanoma of the Skin (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑78: China – Melanoma of the Skin (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑79: China – Breast Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑80: China – Forecast for Breast Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑81: China – Breast (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑82: China – Forecast for Breast (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑83: China – Breast (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑84: China – Forecast for Breast (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑85: China – Cervix Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑86: China – Forecast for Cervix Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑87: China – Uterus Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑88: China – Forecast for Uterus Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑89: China – Ovary Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑90: China – Forecast for Ovary Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑91: China – Prostate Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑92: China – Forecast for Prostate Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑93: China – Testis Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑94: China – Forecast for Testis Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑95: China – Kidney Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑96: China – Forecast for Kidney Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑97: China – Kidney (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑98: China – Forecast for Kidney (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑99: China – Kidney (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑100: China – Forecast for Kidney (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑101: China – Bladder Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑102: China – Forecast for Bladder Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑103: China – Bladder (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑104: China – Forecast for Bladder (Male) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑105: China – Bladder (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑106: China – Forecast for Bladder (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑107: China – Brain, CNS Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑108: China – Forecast for Brain, CNS Test Volume (Thousand), 2017 - 2022
Figure 9‑109: China – Brain, CNS (Male) Cancer Test Volume (Thousand), 2010 – 2016
Figure 9‑110: China – Forecast for Brain, CNS (Male) Test Volume (thousand), 2017 – 2022
Figure 9‑111: China – Brain, CNS (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑112: China – Forecast for Brain, CNS (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑113: China – Thyroid Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑114: China – Forecast for Thyroid Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑115: China – Thyroid (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑116: China – Forecast for Thyroid (Male) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑117: China – Thyroid (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑118: China – Forecast for Thyroid (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑119: China – Lymphoma Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑120: China – Forecast for Lymphoma Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑121: China – Lymphoma (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑122: China – Forecast for Lymphoma (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑123: China – Lymphoma (Female) Cancer Test Volume (Thousand), 2010 – 2016
Figure 9‑124: China – Forecast for Lymphoma (Female) Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑125: China – Leukemia Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑126: China – Forecast for Leukemia Cancer Test Volume (Thousand), 2017 – 2022
Figure 9‑127: China – Leukemia (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑128: China – Forecast for Leukemia (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑129: China – Leukemia (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑130: China – Forecast for Leukemia (Female) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑131: China – All Other and Unspecified Caner Test Volume (Thousand), 2010 - 2016
Figure 9‑132: China – Forecast for All Other and Unspecified Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑133: China – All Other and Unspecified (Male) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑134: China – Forecast for All Other and Unspecified (Male) Cancer Test Volume (Thousand), 2017 - 2022
Figure 9‑135: China – All other and unspecified (Female) Cancer Test Volume (Thousand), 2010 - 2016
Figure 9‑136: China – Forecast for All Other and Unspecified (Female) Cancer Test Volume (Thousand), 2017 - 2022

Figure 10‑1: China – Cancer Deaths (Million), 2010 - 2016
Figure 10‑2: China – Estimation for Cancer Deaths (Million), 2017 – 2022

Figure 11‑1: Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑2: Nasopharynx Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑3: Esophagus Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑4: Stomach Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑5: Colorectum Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑6: Liver Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑7: Gallbladder Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑8: Pancreas Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑9: Larynx Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑10: Lung Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑11: Other Thoracic Organs Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑12: Bone Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑13: Melanoma of the skin Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑14: Breast Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑15: Cervix Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑16: Uterus Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑17: Ovary Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑18: Prostate Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑19: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑20: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑21: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑22: Brain, CNS Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑23: Thyroid Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑24: Lymphoma Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑25: Leukemia Cancer Mortality Rate (Thousand) By Sex, 2015
Figure 11‑26: All other and unspecified Cancer Mortality Rate (Thousand) By Sex, 2015

List of Tables

Table 4‑1: China – Cancer Test Market Share (%), 2010 - 2016
Table 4‑2: China – Forecast for Cancer Test Market Share (%), 2017 - 2022
Table 4‑3: China – Oncology (Male) Test Market Share (%), 2010 - 2016
Table 4‑4: China – Forecast for Oncology (Male) Test Market Share (%), 2017 - 2022
Table 4‑5: China – Cancer (Female) Test Market Share (%), 2010 - 2016
Table 4‑6: China – Forecast for Cancer (Female) Test Market Share (%), 2017 - 2022

Table 6‑1: China – Cancer Test Volume Share (%), 2010 - 2016
Table 6‑2: China – Forecast for Cancer Test Volume Share (%), 2017 - 2022
Table 6‑3: China – Cancer (Male) Test Volume Share (%), 2010 - 2016
Table 6‑4: China – Forecast for Cancer (Male) Test Volume Share (%), 2017 - 2022
Table 6‑5: China – Cancer (Female) Test Volume Share (%), 2010 - 2016
Table 6‑6: China – Forecast for Cancer (Female) Test Volume Share (%), 2017 – 2022
China Petrochemicals Report
The China Petrochemicals Report has been researched at source, and features BMI Research's market assessment and independent forecasts for key petrochemicals sub-sectors. The report also analyses the impact of regulatory changes, recent developments and the background macroeconomic outlook and featu
China Oil and Gas Report
BMI View: China's long-term crude oil and liquids output will remain on a firm downtrend as low oil prices slowdown exploration and render certain high-cost mature and unconventional plays uneconomic. Outlook is more positive for natural gas, as the government seeks to increase the share of ga
China Pharmaceuticals and Healthcare Report
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments 'in China, for China'. The local industry, while stil
China Telecommunications Report
BMI View: Operator strategies will continue to chime with the government's directive to drive uptake of wireline broadband and machine-to-machine (M2M) connections. However, this means that even as subscription numbers rise, the prices of basic services will be compressed and operators will derive p
Global and China Lithium Carbonate Industry Report, 2016-2020
Driven by a surge in sales volume of new energy vehicles in China, the upstream material- lithium carbonate was in short supply in the fourth quarter of 2015 with soaring prices. Global lithium carbonate output increased by 12.3% year on year to 202,800 tons in 2015 and is expected to arrive at 244,

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: